MaxCyte, Inc. MXCT.L Stock
MaxCyte, Inc. Price Chart
MaxCyte, Inc. MXCT.L Financial and Trading Overview
| MaxCyte, Inc. stock price | 330 GBP |
| Previous Close | 400 GBP |
| Open | 390.1 GBP |
| Bid | 395 GBP x 0 |
| Ask | 400 GBP x 0 |
| Day's Range | 385 - 400 GBP |
| 52 Week Range | 280 - 650 GBP |
| Volume | 8.24K GBP |
| Avg. Volume | 40.04K GBP |
| Market Cap | 412.2M GBP |
| Beta (5Y Monthly) | 0.730268 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.29 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.42 GBP |
MXCT.L Valuation Measures
| Enterprise Value | 196.07M GBP |
| Trailing P/E | N/A |
| Forward P/E | -17.391304 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.992703 |
| Price/Book (mrq) | 166.11296 |
| Enterprise Value/Revenue | 4.753 |
| Enterprise Value/EBITDA | -5.905 |
Trading Information
MaxCyte, Inc. Stock Price History
| Beta (5Y Monthly) | 0.730268 |
| 52-Week Change | 24.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 650 GBP |
| 52 Week Low | 280 GBP |
| 50-Day Moving Average | 365.15 GBP |
| 200-Day Moving Average | 447.64 GBP |
MXCT.L Share Statistics
| Avg. Volume (3 month) | 40.04K GBP |
| Avg. Daily Volume (10-Days) | 15.31K GBP |
| Shares Outstanding | 103.05M |
| Float | 101.7M |
| Short Ratio | N/A |
| % Held by Insiders | 1.31% |
| % Held by Institutions | 77.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -73.66% |
| Operating Margin (ttm) | -88.18% |
| Gross Margin | 87.79% |
| EBITDA Margin | -80.49% |
Management Effectiveness
| Return on Assets (ttm) | -7.94% |
| Return on Equity (ttm) | -11.91% |
Income Statement
| Revenue (ttm) | 41.25M GBP |
| Revenue Per Share (ttm) | 0.4 GBP |
| Quarterly Revenue Growth (yoy) | -26.00000000000000000000000000000000% |
| Gross Profit (ttm) | 39.16M GBP |
| EBITDA | -33206400 GBP |
| Net Income Avi to Common (ttm) | -30385100 GBP |
| Diluted EPS (ttm) | -0.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 224.65M GBP |
| Total Cash Per Share (mrq) | 2.18 GBP |
| Total Debt (mrq) | 16.25M GBP |
| Total Debt/Equity (mrq) | 6.56 GBP |
| Current Ratio (mrq) | 14.811 |
| Book Value Per Share (mrq) | 2.408 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15413400 GBP |
| Levered Free Cash Flow (ttm) | -22284938 GBP |
Profile of MaxCyte, Inc.
| Country | United Kingdom |
| State | MD |
| City | Rockville |
| Address | 9713 Key West Avenue |
| ZIP | 20850 |
| Phone | 301 944 1700 |
| Website | https://maxcyte.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 125 |
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Q&A For MaxCyte, Inc. Stock
What is a current MXCT.L stock price?
MaxCyte, Inc. MXCT.L stock price today per share is 330 GBP.
How to purchase MaxCyte, Inc. stock?
You can buy MXCT.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MaxCyte, Inc.?
The stock symbol or ticker of MaxCyte, Inc. is MXCT.L.
Which industry does the MaxCyte, Inc. company belong to?
The MaxCyte, Inc. industry is Medical Devices.
How many shares does MaxCyte, Inc. have in circulation?
The max supply of MaxCyte, Inc. shares is 1.04M.
What is MaxCyte, Inc. Price to Earnings Ratio (PE Ratio)?
MaxCyte, Inc. PE Ratio is now.
What was MaxCyte, Inc. earnings per share over the trailing 12 months (TTM)?
MaxCyte, Inc. EPS is -0.29 GBP over the trailing 12 months.
Which sector does the MaxCyte, Inc. company belong to?
The MaxCyte, Inc. sector is Healthcare.